Department of Pediatric Perioperative Medicine and Intensive Care, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Eur J Pediatr. 2024 Apr;183(4):1703-1709. doi: 10.1007/s00431-024-05432-7. Epub 2024 Jan 16.
The use of outpatient parenteral antimicrobial therapy (OPAT) for children has several advantages, including reduced length of hospital stay and costs. A reliable vascular access is key to delivering safe and effective pediatric OPAT. In recent years, midline catheters (MC) have been increasingly used for short-term intravenous antibiotic therapy in children. However, there are no studies investigating the use of MCs in the OPAT setting. The main aim of this paper was to evaluate the success and complications of using MCs for pediatric OPAT. This was a retrospective cohort study from a tertiary academic pediatric hospital. All MCs inserted at the hospital and used for OPAT were eligible for study inclusion. The primary objective was to describe the percentage of patients able to complete OPAT without the need for additional venous access. Forty-one MCs were included in the study. Patient mean (SD) age was 5.9 (4.9) years. In 31 cases (76%, 95% CI 62-86%), the iv therapy could be successfully completed using only the MC. Imbalances between the groups suggested unfavorable outcome for saphenous vein catheters as well as for shorter and smaller-sized catheters. Fourteen patients (34%) were subjected to a MC-related complication. Pain on injection in the MC was the most frequent complication (n = 10, 24%). Conclusion: Midline catheters could be an alternative to central venous access for pediatric OPAT. Avoiding saphenous vein insertion and using longer and larger-sized catheters could increase MC success rate. No severe MC-related complication was found. Further randomized studies comparing different catheter types are needed. What is Known: • For selected patients, pediatric outpatient parenteral antimicrobial therapy (OPAT) is safe and provides health-economic, psychosocial, and medical advantages compared to in-hospital care. • A reliable venous access is one of the key factors to the success of OPAT, but this can be a challenge in children. What is New: • Using midline catheters, 76% of patients could complete their intended iv therapy without the need for additional venous access. Avoiding saphenous vein insertion and using longer and larger-sized catheters could increase the success rate. • Thirty-four percent of catheters were subject to some kind of complication, the most common being pain on injection in the catheter.
门诊患者的肠外抗菌治疗(OPAT)有几个优点,包括减少住院时间和降低成本。可靠的血管通路是提供安全有效的儿科 OPAT 的关键。近年来,中线导管(MC)已越来越多地用于儿童短期静脉内抗生素治疗。然而,目前尚无研究调查 MC 在 OPAT 环境中的使用情况。本文的主要目的是评估 MC 用于儿科 OPAT 的成功率和并发症。这是一项来自三级学术儿科医院的回顾性队列研究。所有在医院插入并用于 OPAT 的 MC 都符合研究纳入标准。主要目的是描述无需额外静脉通路即可完成 OPAT 的患者比例。该研究纳入了 41 例 MC。患者平均(SD)年龄为 5.9(4.9)岁。在 31 例(76%,95%CI 62-86%)中,仅使用 MC 即可成功完成 IV 治疗。组间的不平衡表明,大隐静脉导管以及较短和较小的导管结局不利。14 例患者(34%)发生与 MC 相关的并发症。MC 注射时疼痛是最常见的并发症(n=10,24%)。结论:MC 可作为儿科 OPAT 的中心静脉通路的替代方法。避免大隐静脉插入并使用较长和较大的导管可以提高 MC 的成功率。未发现严重的 MC 相关并发症。需要进一步进行比较不同导管类型的随机研究。已知:•对于选定的患者,儿科门诊患者的肠外抗菌治疗(OPAT)是安全的,与住院治疗相比,提供了健康经济、心理社会和医疗方面的优势。•可靠的静脉通路是 OPAT 成功的关键因素之一,但这在儿童中可能是一个挑战。新内容:•使用 MC,76%的患者无需额外的静脉通路即可完成其预期的 IV 治疗。避免大隐静脉插入并使用较长和较大的导管可以提高成功率。•34%的导管发生了某种并发症,最常见的是导管注射时疼痛。